Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- GLs for Proper Use of Anticancer Drugs Presented: Meeting
February 25, 2002
- BUSINESS NEWS IN BRIEF
February 25, 2002
- Treatment GLs for Hyperuricemia, Gout Announced: Society Meeting
February 25, 2002
- WEBSITE NEWS
February 25, 2002
- 700 Renal Transplants Performed in 2001: Meeting
February 25, 2002
- Details of FY2002 NHI Pricing System Reform Approved by Chuikyo
February 25, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
February 25, 2002
- NHI Pricing System Needs Reform from Mid-, Long-term Perspectives: EAD Director, FPMAJ
February 25, 2002
- Japanese Language Books
February 25, 2002
- LDP Listens to Industry's Views on Pharmaceutical Regulations
February 25, 2002
- Consumers' Interest in Self-medication Increases: PAJ Survey
February 25, 2002
- Reform Should Promote Industry: LDP Diet Member
February 25, 2002
- Matsumotokiyoshi Ties Up with Shimizu Yakuhin
February 25, 2002
- PFSB to Computerize All Administrative Procedures in FY2003
February 25, 2002
- Suzuken: New Blood Pressure Monitors
February 25, 2002
- Medical Institutions Should Join Discussions on Distribution Reform: Mr Matsutani of FJPWA
February 25, 2002
- Bio Media: New Sprayer for Sterilization
February 25, 2002
- Yamanouchi Expects 50% of Its Asian Sales in China
February 25, 2002
- AstraZeneca: Sales Up 8% to US$16,480 Mil.
February 25, 2002
- JPMA to Continue to Demand Better Protection of NDA Dossiers
February 25, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…